# Asthma Clinical Research Network (ACRN) Trial - Long-Acting Beta Agonist Response by Genotype (LARGE)

> **NCT00200967** · PHASE3 · COMPLETED · sponsor: **Milton S. Hershey Medical Center** · enrollment: 87 (actual)

## Conditions studied

- Asthma

## Interventions

- **DRUG:** salmeterol
- **DRUG:** beclomethasone HFA

## Key facts

- **NCT ID:** NCT00200967
- **Lead sponsor:** Milton S. Hershey Medical Center
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2004-12
- **Primary completion:** 2008-02
- **Final completion:** 2008-02
- **Target enrollment:** 87 (ACTUAL)
- **Last updated:** 2018-01-23

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00200967

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00200967, "Asthma Clinical Research Network (ACRN) Trial - Long-Acting Beta Agonist Response by Genotype (LARGE)". Retrieved via AI Analytics 2026-06-14 from https://api.ai-analytics.org/clinical/NCT00200967. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*